These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

376 related articles for article (PubMed ID: 21470141)

  • 1. Cell penetrating peptides for tumor targeting.
    Choi YS; Lee JY; Suh JS; Lee SJ; Yang VC; Chung CP; Park YJ
    Curr Pharm Biotechnol; 2011 Aug; 12(8):1166-82. PubMed ID: 21470141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell-penetrating peptides: strategies for anticancer treatment.
    Raucher D; Ryu JS
    Trends Mol Med; 2015 Sep; 21(9):560-70. PubMed ID: 26186888
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential efficacy of cell-penetrating peptides for nucleic acid and drug delivery in cancer.
    Bolhassani A
    Biochim Biophys Acta; 2011 Dec; 1816(2):232-46. PubMed ID: 21840374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Challenge to overcome current limitations of cell-penetrating peptides.
    Kim GC; Cheon DH; Lee Y
    Biochim Biophys Acta Proteins Proteom; 2021 Apr; 1869(4):140604. PubMed ID: 33453413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell penetrating peptides: the potent multi-cargo intracellular carriers.
    Kardani K; Milani A; H Shabani S; Bolhassani A
    Expert Opin Drug Deliv; 2019 Nov; 16(11):1227-1258. PubMed ID: 31583914
    [No Abstract]   [Full Text] [Related]  

  • 6. Applicability and Limitations of Cell-Penetrating Peptides in Noncovalent Mucosal Drug or Carrier Delivery Systems.
    Kamei N; Bech Nielsen EJ; Nakakubo T; Aoyama Y; Rahbek UL; Pedersen BL; Takeda-Morishita M
    J Pharm Sci; 2016 Feb; 105(2):747-753. PubMed ID: 26869427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Taming Cell Penetrating Peptides: Never Too Old To Teach Old Dogs New Tricks.
    Zhang Q; Gao H; He Q
    Mol Pharm; 2015 Sep; 12(9):3105-18. PubMed ID: 26237247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell penetrating peptides: efficient vectors for delivery of nanoparticles, nanocarriers, therapeutic and diagnostic molecules.
    Farkhani SM; Valizadeh A; Karami H; Mohammadi S; Sohrabi N; Badrzadeh F
    Peptides; 2014 Jul; 57():78-94. PubMed ID: 24795041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell-penetrating peptides in protein mimicry and cancer therapeutics.
    Zorko M; Jones S; Langel Ü
    Adv Drug Deliv Rev; 2022 Jan; 180():114044. PubMed ID: 34774552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A survey on "Trojan Horse" peptides: opportunities, issues and controlled entry to "Troy".
    Shi NQ; Qi XR; Xiang B; Zhang Y
    J Control Release; 2014 Nov; 194():53-70. PubMed ID: 25151981
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell penetration: scope and limitations by the application of cell-penetrating peptides.
    Reissmann S
    J Pept Sci; 2014 Oct; 20(10):760-84. PubMed ID: 25112216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent advances of anti-cancer therapies including the use of cell-penetrating peptides.
    Klimpel A; Lützenburg T; Neundorf I
    Curr Opin Pharmacol; 2019 Aug; 47():8-13. PubMed ID: 30771730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell-penetrating peptides: a useful tool for the delivery of various cargoes into cells.
    Böhmová E; Machová D; Pechar M; Pola R; Venclíková K; Janoušková O; Etrych T
    Physiol Res; 2018 Oct; 67(Suppl 2):S267-S279. PubMed ID: 30379549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic delivery opportunities, obstacles and applications for cell-penetrating peptides.
    Lindberg S; Copolovici DM; Langel U
    Ther Deliv; 2011 Jan; 2(1):71-82. PubMed ID: 22833926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell-penetrating Peptides for Cancer-targeting Therapy and Imaging.
    Wang W; Abbad S; Zhang Z; Wang S; Zhou J; Lv H
    Curr Cancer Drug Targets; 2015; 15(4):337-51. PubMed ID: 25669720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The cell-type specificity and endosomal escape of cell-penetrating peptides.
    Feng J; Tang L
    Curr Pharm Des; 2015; 21(10):1351-6. PubMed ID: 25341672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent developments in anticancer drug delivery using cell penetrating and tumor targeting peptides.
    Dissanayake S; Denny WA; Gamage S; Sarojini V
    J Control Release; 2017 Mar; 250():62-76. PubMed ID: 28167286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CPP-Assisted Intracellular Drug Delivery, What Is Next?
    Ye J; Liu E; Yu Z; Pei X; Chen S; Zhang P; Shin MC; Gong J; He H; Yang VC
    Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27854260
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor-targeting delivery of herb-based drugs with cell-penetrating/tumor-targeting peptide-modified nanocarriers.
    Kebebe D; Liu Y; Wu Y; Vilakhamxay M; Liu Z; Li J
    Int J Nanomedicine; 2018; 13():1425-1442. PubMed ID: 29563797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Current Role of Cell-Penetrating Peptides in Cancer Therapy.
    Feni L; Neundorf I
    Adv Exp Med Biol; 2017; 1030():279-295. PubMed ID: 29081059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.